Assessing the severity of tricuspid regurgitation remains a challenging task, and although
echocardiography is the test of choice, significant limitations of the current recommendations …

Tricuspid regurgitation (TR) is classified according to different morphologic types based on
the underlying mechanisms: primary, secondary, and isolated TR. Primary TR is caused by …

Valvular regurgitation represents an important cause of cardiovascular morbidity and
mortality. Imaging is pivotal in the evaluation of native valve regurgitation and …

Transcatheter tricuspid valve interventions (TTVIs) comprise a variety of catheter-based
interventional techniques for treatment of tricuspid regurgitation (TR) in patients at high …

The characterization of tricuspid valve and right-heart anatomy has been gaining significant
interest in the setting of new percutaneous transcatheter interventions for tricuspid …

Objectives The authors report etiologies and outcomes and devise a risk model in a large
contemporary cohort of patients with isolated tricuspid regurgitation (TR). Background …

Transcatheter interventions to treat mitral and tricuspid valve disease are becoming
increasingly available because of the growing number of elderly patients with significant …

Tricuspid regurgitation (TR) is present in 1.6 million individuals in the United States and 3.0
million people in Europe. Functional TR, the most common form of TR, is caused by …

Tricuspid regurgitation (TR) is a highly prevalent and heterogeneous valvular disease,
independently associated with excess mortality and high morbidity in all clinical contexts. TR …

Valvular regurgitation is common in developed countries with an increasing prevalence due
to the aging of the population and more accurate diagnostic imaging methods …